Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (KYMR) 財務データ

損益計算書

四半期ごと

*すべての数値は百万単位です

期間終了日	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
期間の長さ	3 か月	3 か月	3 か月	3 か月	3 か月
Revenues	912.80% 47.88	4.728	16.51	9.466	16.14
Operating Expenses	7.97% 67.20	62.24	59.90	54.79	54.77
Benefits Costs and Expenses	225.55	-	-	50.39	51.00
Costs And Expenses	21.86% 48.63	62.24	59.90	50.39	51.00
Operating Income/Loss	66.42% -19.31	-57.51	-43.38	-45.33	-38.63
Income/Loss From Continuing Operations Before Tax	3,858% -177.67	4.728	16.51	-40.93	-34.87
Income/Loss From Continuing Operations After Tax	72.82% -14.37	-52.87	-38.80	-40.93	-34.87
Net Income/Loss	72.82% -14.37	-52.87	-38.80	-40.93	-34.87
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.91% 0.0527	58.42	58.33	58.19	1.3331
Diluted Average Shares	99.91% 0.0527	58.42	58.33	58.19	1.3331
Basic Earnings Per Share	72.22% -0.25	-0.90	-0.67	-0.70	-0.59
Diluted Earnings Per Share	72.22% -0.25	-0.90	-0.67	-0.70	-0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-